Chemical Technology

EH&S GUIDELINES FOR PEROXIDE FORMING CHEMICALS

August 11, 2022

EH&S GUIDELINES
This guide will help you manage your peroxide forming chemicals and outlines the procedures for the required stabilization of peroxide forming chemicals and destruction of peroxides prior to disposal.

Spotlight

Kite Pharma, Inc.

Kite Pharma is dedicated to achieving one of the most ambitious goals of 21st century medicine: curing cancer. This mission is at the heart of everything we do, from early research to product development. For the past three decades, members of our team have been at the forefront of cancer immunotherapy. Today, we are a leader in engineered T cell therapy, transforming cancer treatment with what is potentially the biggest breakthrough since the introduction of combination chemotherapy more than 60 years ago. To bring about this transformation, we’re developing innovative products that harness a patient’s own immune system to target and kill cancer cells. Early clinical studies in patients who were treated with engineered T cells have produced dramatic results thus far, up to and including complete remission of cancer in some patients who have aggressive disease and have not responded to other therapies. In all areas of the company, we are looking for the very best people who share our d

OTHER WHITEPAPERS
news image

Exploring quantum use cases for chemicals and petroleum

whitePaper | December 19, 2019

classically, the algorithms have exponential scaling. However, due to the nature of quantum algorithms, chemistry calculations have been predicted to scale polynomially, a promising step towards the ability to perform exact calculations on molecules that are currently out of reach.

Read More
news image

Digital Lifecycle Excellence in the Energy & Utilities Industry

whitePaper | July 12, 2021

Learn how to apply physical and digital assets to deliver top performance across all categories. Today, modern energy and utility companies are faced with the complex task of getting more value from their physical assets and supporting data to improve efficiency and reduce costs. Using a digital lifecycle excellence approach to organize and consolidate that data will provide opportunities to increase competitiveness across your organization.

Read More
news image

Monitoring chemical recycling

whitePaper | April 13, 2022

To reach environmental goals regarding climate change and the circular economy, the recycling rate of plastics has to increase considerably over the coming years.

Read More
news image

Investor Update October 2022

whitePaper | October 11, 2022

Completed to acquire additional stakes in Lotus Pharmaceutical to be 37% and invest in Adalvo 60%. Profit contribution started in 2Q22

Read More
news image

Specifications Guide European Petrochemicals

whitePaper | September 12, 2022

Assessment Window: Assessments are based on the latest information from the market up to the close of the assessment

Read More
news image

Silicone-Base Coating Mitigates Corrosion Under Insulation (CUI) In Petrochemical Plants

whitePaper | June 15, 2021

Corrosion under insulation (CUI) is one of the costliest problems in the petrochemical industry. It also presents a high degree of potential danger. CUI occurs when moisture mixed with contaminants infiltrates insulation, encouraging the development of corrosion cells on the steel underneath. This paper demonstrates how Sherwin-Williams Heat-Flex® High-Temp 1200 withstands temperature fluctuations, thermal shock and other upset conditions to protect against hidden CUI.

Read More

Spotlight

Kite Pharma, Inc.

Kite Pharma is dedicated to achieving one of the most ambitious goals of 21st century medicine: curing cancer. This mission is at the heart of everything we do, from early research to product development. For the past three decades, members of our team have been at the forefront of cancer immunotherapy. Today, we are a leader in engineered T cell therapy, transforming cancer treatment with what is potentially the biggest breakthrough since the introduction of combination chemotherapy more than 60 years ago. To bring about this transformation, we’re developing innovative products that harness a patient’s own immune system to target and kill cancer cells. Early clinical studies in patients who were treated with engineered T cells have produced dramatic results thus far, up to and including complete remission of cancer in some patients who have aggressive disease and have not responded to other therapies. In all areas of the company, we are looking for the very best people who share our d

Events